查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1538540

自註射注射药物市场报告：2030 年趋势、预测与竞争分析

Self-Administered Parenteral Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

自行注射药物的趋势和预测

预计 2024 年至 2030 年，全球自行给药注射药物市场将以 5.5% 的复合年增长率成长。该市场的主要驱动力是特种药物和生技药品的重要性日益增加、家庭治疗方案的接受度不断提高以及智慧注射工具的使用不断增加。全球自行注射药物市场的未来充满希望，心血管疾病、糖尿病、骨质疏鬆症、疼痛管理和荷尔蒙替代市场充满机会。

自行注射药物细分

该研究包括按产品类型、用途、分销管道、应用和地区对全球自行给药注射药物的预测。

自行给药注射药物市场洞察

Lucintel 预测，由于对实用和安全的给药系统的需求不断增加，预填充式注射器将在预测期内实现最高增长。

在这个市场中，疼痛管理预计将在预测期内实现最高成长。

预计亚太地区在预测期内将出现最高成长。

常问问题

Q1.市场成长预测是多少：

A1. 2024年至2030年，全球自行注射药物市场预计将以5.5%的复合年增长率成长。

Q2. 影响市场成长的关键驱动因素是：

A2. 该市场的主要驱动力是特种药物和生技药品的重要性日益增加、家庭治疗方案的接受度不断提高以及智慧注射工具的使用不断增加。

Q3.市场的主要细分市场是：

A3. 自用注射药物市场前景广阔，在心血管疾病、糖尿病、骨质疏鬆症、疼痛管理和荷尔蒙替代市场方面存在机会。

Q4.市场的主要企业是：

A4. 一些主要企业如下：

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections

Q5.未来最大的细分市场是什么？

A5.Lucintel 预测，由于对实用和安全的给药系统的需求不断增加，预填充式注射器预计将在预测期内实现最高增长。

Q6.未来五年预计哪些地区的市场成长最大？

A6.APAC 预计在预测期内成长最快。

Q7. 可以客製化报告吗？

A7。

目录

第一章执行摘要

第二章全球自行注射药物市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球自行注射药物市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球自行给药注射药物市场
    • 预填充式注射器
    • 自动注射器
    • 笔式註射器
    • 其他的
  • 按使用方法分類的全球自行给药注射药物市场
    • 一次性的
    • 可重复使用的
  • 按分销管道分類的全球自行给药注射药物市场
    • 医院药房
    • 网路药房
    • 居家医疗提供者
    • 专科诊所
    • 其他的
  • 全球自行给药注射药物市场（依应用）
    • 心血管疾病
    • 糖尿病
    • 骨质疏鬆症
    • 疼痛管理
    • 荷尔蒙补充疗法
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球自用注射药物市场区域分布
  • 北美自行给药注射药物市场
  • 欧洲自行注射药物市场
  • 亚太地区自行给药注射药物市场
  • 其他区域自行注射药物市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球自行给药注射药物市场成长机会
    • 全球自行给药注射药物市场成长机会（依使用方法）
    • 全球自行给药注射药物市场成长机会（依分销管道）
    • 全球自行给药注射药物市场成长机会（依应用）
    • 按地区分類的全球自行给药注射药物市场成长机会
  • 全球自行注射药物市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球自行给药注射药物市场的产能
    • 全球自行给药注射药物市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections
简介目录

Self-Administered Parenteral Trends and Forecast

The future of the global self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets. The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Self-Administered Parenteral by Segment

The study includes a forecast for the global self-administered parenteral by product type, usage, distribution channel, application, and region.

Self-Administered Parenteral Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Pre-Filled Syringes
  • Auto injectors
  • Pen Injectors
  • Others

Self-Administered Parenteral Market by Usage [Shipment Analysis by Value from 2018 to 2030]:

  • Disposable
  • Reusable

Self-Administered Parenteral Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Online Pharmacies
  • Home Healthcare Providers
  • Specialty Clinics
  • Others

Self-Administered Parenteral Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiovascular Diseases
  • Diabetes
  • Osteoporosis
  • Pain Management
  • Hormone Replacement
  • Others

Self-Administered Parenteral Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Self-Administered Parenteral Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies self-administered parenteral companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the self-administered parenteral companies profiled in this report include-

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections

Self-Administered Parenteral Market Insights

Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.

Within this market, pain management is expected to witness the highest growth over the forecast period.

APAC is expected to witness the highest growth over the forecast period.

Features of the Global Self-Administered Parenteral Market

Market Size Estimates: Self-administered parenteral market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Self-administered parenteral market size by various segments, such as by product type, usage, distribution channel, application, and region in terms of value ($B).

Regional Analysis: Self-administered parenteral market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, usages, distribution channels, applications, and regions for the self-administered parenteral market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the self-administered parenteral market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for self-administered parenteral market?

Answer: The global self-administered parenteral market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the self-administered parenteral market?

Answer: The major drivers for this market are growing significance of specialty drugs & biologics, increasing acceptance of options for home-based therapy, and growing use of smart injection tools.

Q3. What are the major segments for self-administered parenteral market?

Answer: The future of the self-administered parenteral market looks promising with opportunities in the cardiovascular disease, diabetes, osteoporosis, pain management, and hormone replacement markets.

Q4. Who are the key self-administered parenteral market companies?

Answer: Some of the key self-administered parenteral companies are as follows:

  • Becton, Dickinson and Company
  • scPharmaceuticals
  • Harro Hofliger
  • Owen Mumford
  • Haselmeier
  • Stevanato Group
  • Ypsomed AG
  • Solteam Group
  • AstraZeneca
  • Enable Injections

Q5. Which self-administered parenteral market segment will be the largest in future?

Answer: Lucintel forecasts that pre-filled syringe is expected to witness the highest growth over the forecast period due to its growing demand for practical and safe medicine delivery systems.

Q6. In self-administered parenteral market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness the highest growth over the forecast period.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the self-administered parenteral market by product type (pre-filled syringes, auto injectors, pen injectors, and others), usage (disposable and reusable), distribution channel (hospital pharmacies, online pharmacies, home healthcare providers, specialty clinics, and others), application (cardiovascular diseases, diabetes, osteoporosis, pain management, hormone replacement, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Self-Administered Parenteral Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Self-Administered Parenteral Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Self-Administered Parenteral Market by Product Type
    • 3.3.1: Pre-Filled Syringes
    • 3.3.2: Auto injectors
    • 3.3.3: Pen Injectors
    • 3.3.4: Others
  • 3.4: Global Self-Administered Parenteral Market by Usage
    • 3.4.1: Disposable
    • 3.4.2: Reusable
  • 3.5: Global Self-Administered Parenteral Market by Distribution Channel
    • 3.5.1: Hospital Pharmacies
    • 3.5.2: Online Pharmacies
    • 3.5.3: Home Healthcare Providers
    • 3.5.4: Specialty Clinics
    • 3.5.5: Others
  • 3.6: Global Self-Administered Parenteral Market by Application
    • 3.6.1: Cardiovascular Diseases
    • 3.6.2: Diabetes
    • 3.6.3: Osteoporosis
    • 3.6.4: Pain Management
    • 3.6.5: Hormone Replacement
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Self-Administered Parenteral Market by Region
  • 4.2: North American Self-Administered Parenteral Market
    • 4.2.1: North American Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.2.2: North American Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
  • 4.3: European Self-Administered Parenteral Market
    • 4.3.1: European Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.3.2: European Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
  • 4.4: APAC Self-Administered Parenteral Market
    • 4.4.1: APAC Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.4.2: APAC Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others
  • 4.5: ROW Self-Administered Parenteral Market
    • 4.5.1: ROW Self-Administered Parenteral Market by Product Type: Pre-Filled Syringes, Auto injectors, Pen Injectors, and Others
    • 4.5.2: ROW Self-Administered Parenteral Market by Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Self-Administered Parenteral Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Self-Administered Parenteral Market by Usage
    • 6.1.3: Growth Opportunities for the Global Self-Administered Parenteral Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Self-Administered Parenteral Market by Application
    • 6.1.5: Growth Opportunities for the Global Self-Administered Parenteral Market by Region
  • 6.2: Emerging Trends in the Global Self-Administered Parenteral Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Self-Administered Parenteral Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Self-Administered Parenteral Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Becton, Dickinson and Company
  • 7.2: scPharmaceuticals
  • 7.3: Harro Hofliger
  • 7.4: Owen Mumford
  • 7.5: Haselmeier
  • 7.6: Stevanato Group
  • 7.7: Ypsomed AG
  • 7.8: Solteam Group
  • 7.9: AstraZeneca
  • 7.10: Enable Injections